MehShit news on the antiviral front. Merck product looks good, Pfizer still on the way, but Atea was the 3rd horse that was at later stage than the others.
Atea Pharmaceuticals said Tuesday that its antiviral pill for Covid-19 failed to combat the virus in a mid-stage trial.www.statnews.com
Thank god I sold their stock after 70% gains
Hopefully this is incorrect. Would be nice if the antivirals worked well for everyone.